Position in BMY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$88,878,511
+$29,106,465 QoQ
Shares Held
1,465,433
+32.2% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$997,890
PutShares
18,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $2,972,093,575 across 11 Drug Manufacturers - General names. BMY ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,409,868 | $1,077,948,133 | |
| 2 | LLY |
ELI LILLY & Co
|
506,081 | $465,478,121 | |
| 3 | ABBV |
AbbVie Inc.
|
2,065,016 | $449,120,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,517,435 | $302,822,256 | |
| 5 | AZN |
Astrazeneca PLC
|
1,444,637 | $284,911,309 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,017,219 | $141,769,812 | |
| 7 | PFE |
Pfizer Inc
|
3,274,513 | $91,948,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
1,465,433 | $88,878,511 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $88,878,511 | 1,465,433 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $59,772,046 | 1,108,121 | Shares | Sole | 2026-02-18 | |
| 2025-12-31 | $997,890 | 18,500 | Put | Sole | 2026-02-18 | |
| 2025-09-30 | $56,576,642 | 1,254,471 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $52,139,667 | 1,126,370 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $999,864 | 21,600 | Put | Sole | 2025-08-13 | |
| 2025-03-31 | $54,926,130 | 900,576 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $33,130,924 | 585,766 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $16,449,336 | 317,923 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,999,810 | 505,654 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $31,625,634 | 583,176 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $31,387,045 | 611,714 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $25,745,325 | 443,579 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $30,419,288 | 475,673 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $47,532,035 | 685,789 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $47,729,327 | 663,368 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $49,878,023 | 701,618 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $50,593,620 | 657,060 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $24,725,255 | 338,563 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $16,868,480 | 270,545 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,307,348 | 326,303 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $18,859,009 | 282,236 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $16,239,434 | 257,238 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,743,643 | 189,322 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $11,539,867 | 191,406 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,263,140 | 191,550 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||